Updated guidelines 2008 for the diagnosis, surveillance and therapy of Barrett's esophagus

American Journal of Gastroenterology

Volumn 103, Issue 3, 2008, Pages 788-797

  Wang, Kenneth K ^a   Sampliner, Richard E ^a,b  

^a Practice Parameters Committee

^b Department of Surgery   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; PROSTAGLANDIN SYNTHASE INHIBITOR; PROTON PUMP INHIBITOR;

ARGON PLASMA COAGULATION; BARRETT ESOPHAGUS; CAPSULE ENDOSCOPY; CHEMOPROPHYLAXIS; CLINICAL PROTOCOL; DIAGNOSTIC APPROACH ROUTE; DISEASE SURVEILLANCE; DYSPLASIA; ESOPHAGEAL ADENOCARCINOMA; ESOPHAGOSCOPY; ESOPHAGUS BIOPSY; ESOPHAGUS RESECTION; GASTROESOPHAGEAL REFLUX; HUMAN; INTESTINE METAPLASIA; NONHUMAN; PHOTODYNAMIC THERAPY; PRACTICE GUIDELINE; PRIORITY JOURNAL; RADIOFREQUENCY ABLATION; REVIEW; TREATMENT INDICATION;

BARRETT ESOPHAGUS; BIOLOGICAL MARKERS; ESOPHAGUS; HUMANS;

EID: 40949156279     PISSN: 00029270     EISSN: 15720241     Source Type: Journal    
DOI: 10.1111/j.1572-0241.2008.01835.x     Document Type: Review

References (90)

1. Pohl H, Welch HG. The role of overdiagnosis and reclassification in the marked increase of esophageal adenocarcinoma incidence. JNCI 2005 97 (2 142 46.
2. van Blankenstein M, Looman CWN, Hop WC, et al. The incidence of adenocarcinoma and squamous cell carcinoma of the esophagus: Barrett's esophagus makes a difference. Am J Gastro 2005 100 : 766 74.
3. Sharma P, McQuaid KR, Dent J, et al. A critical review of the diagnosis and management of Barrett's esophagus: the AGA Chicago workshop. Gastroenterology 2004 127 : 310 30.
4. Haggitt RC, Tryzelaar J, Ellis FH, et al. Adenocarcinoma complicating columnar epithelium lined (Barrett's) esophagus. AJCP 1978 70 : 1 5.
5. Skinner DB, Walther BC, Riddell RH, et al. Barrett's esophagus: comparison of benign and malignant cases. Ann Surg 1983 198 : 554 66.
6. Smith RRL, Hamilton SO, Boitnott JK, et al. The spectrum of carcinoma arising in Barrett's esophagus. Am J Burg Pathol 1984 8 : 563 73.
7. Rosenberg JO, Budev H, Edwards RC, et al. Analysis of adenocarcinoma in Barrett's esophagus utilizing a staging system. Cancer 1985 55 : 1353 60.
8. Paraf F, Flejou JF, Pignon JP, et al. Surgical pathology of adenocarcinoma arising in Barrett's esophagus. Am J Surg Pathol 1995 19 : 183 91.
9. Cameron AJ, Lomboy CT, Pera M, et al. Adenocarcinoma of the esophagogastric junction in Barrett's esophagus. Gastroenterology 1995 109 : 1541 46.
10. Clark GW, Smyrk TC, Burdiles P, et al. Is Barrett's metaplasia the source of adenocarcinomas of the cardia? Arch Surg. 1994 129 : 609 14.
11. MacDonald WC, Macdonald JB. Adenocarcinoma of the esophagus and/or gastric cardia. Cancer 1987 : 1094 98.
12. Brown LM, Devesa SS. Epidemiologic trends in esophageal and gastric cancer in the United States. Surg Oncol Clin N Am 2002 11 : 235 56.
13. Theisen J, Stein HJ, Dittler HJ, et al. Preoperative chemotherapy unmasks underlying Barrett's mucosa in patients with adenocarcinoma of the distal esophagus. Surg Endosc 2002 : 671 73.
14. Hanna S, Rastogi A, Weston AP, et al. Detection of Barrett's esophagus after endoscopic healing for erosive esophagitis. Am J Gastro 2006 101 : 1416 20.
15. Society BG. Guidelines for the diagnosis and management of Barrett's columnar-lined oesophagus. http://www.bsg.org.uk. In : Gastroenterology BSo, ed 2005.
16. Oberg S, Johansson J, Wenner J, et al. Endoscopic surveillance of columnar-lined esophagus: frequency of intestinal metaplasia detection and impact of antireflux surgery. Ann Surg 2001 234 : 619 26.
17. Jones TF, Sharma P, Daaboul B, et al. Yield of intestinal metaplasia in patients with suspected short-segment Barrett's esophagus (SSBE) on repeat endoscopy. Dig Dis Sci 2002 47 (9 108 11.
18. Harrison R, Perry I, Haddadin W, et al. Detection of intestinal metaplasia in Barrett's esophagus: an observational comparator study suggests the need for a minimum of eight biopsies. Am J Gastro 2007 102 : 1154 61.
19. Shaheen NJ, Dulai GS, Ascher B, et al. Effect of a new diagnosis of Barrett's esophagus on insurance status. Am J Gastro 2005 100 : 577 80.
20. Sharma P, Dent J, Armstrong D, et al. The development and validation of an endoscopic grading system for Barrett's esophagus: the Prague C & M criteria. Gastroenterology 2006 131 : 1392 99.
21. Eloubeide MA, Provenzale D. Clinical and demographic predictors of Barrett's esophagus among patients with gastroesophageal reflux disease. J Clin Gastroenterol 2001 33 (4 306 9.
22. Gerson LB, Edson R, Lavori PW, et al. Use of a simple symptom questionnaire to predict Barrett's esophagus in patients with symptoms of gastroesophageal reflux. Am J Gastroenterol 2001 96 : 2005 12.
23. Conio M, Filiberti R, Blanchi S, et al. Risk factors for Barrett's esophagus: a case-control study. Int J Cancer 2002 97 : 225 29.
24. El-Serag HB, Kvapil P, Hacken-Bitar J, et al. Abdominal obesity and the risk of Barrett's esophagus. Am J Gastro 2005 100 : 2151 56.
25. Sharma P, Rastojg A, Esquivel R, et al. Accuracy of wireless capsule endoscopy for the detection of Barrett's esophagus. Gastroenterology. 2006 130 (4 (Suppl 2 A262 (S1812).
26. Lin O, Schembre DB, KM, et al. Blinded comparison of esophageal capsule endoscopy versus conventional endoscopy for diagnosis of Barrett's esophagus in patients with chronic gastroesophageal reflux. Gastrointest Endosc 2007 65 (4 577 83.
27. Ronkainen J, Aro P, Storskrubb T, et al. Prevalence of Barrett's esophagus in the general population: an endoscopic study. Gastroenterology 2005 129 : 1825 31.
28. Corley DA, Levin TR, Habel LA, et al. Surveillance and survival in Barrett's adenocarcinomas: a population-based study. Gastroenterology 2002 122 : 633 40.
29. Cooper GS. Endoscopic screening and surveillance for Barrett's esophagus: Can claims data determine its effectiveness? Gastrointest Endosc. 2003 57 (7 914 15.
30. Falk GW, Ours TM, Richter J. Practice patterns for surveillance of Barrett's esophagus in the United States. Gastrointest Endosc 2000 52 : 197 203.
31. Gross GP, Canto MI, Hixson J, et al. Management of Barrett's esophagus: a national study of practice patterns and their cost implications. Am J Gastroenterol 1999 94 (12 3440 7.
32. Eloubeide MA, Mason AC, Desmond RA, et al. Temporal trends (1973-1997) in survival of patients with esophageal adenocarcinoma in the United States: A glimmer of hope? Am J Gastroenterol. 2003 98 (7 1627 33.
33. Sharma P, Falk GA, Weston AP, et al. Dysplasia and cancer in a large multicenter cohort of patients with Barrett's esophagus. Clin Gastroenterol and Hepatol 2006 4 : 566 72.
34. Montgomery E, Bronner MP, Goldblum JR, et al. Reproducibility of the diagnosis of dysplasia in Barrett's esophagus: a reaffirmation. Hum Pathol 2001 32 : 368 78.
35. Skacel M, Petras R, Gramlich TL, et al. The diagnosis of low-grade dysplasia in Barrett's esophagus and its implications for disease progression. Am J Gastroenterol 2000 95 : 3383 87.
36. Reid BJ, Blount P, Feng Z, et al. Optimizing endoscopic biopsy detection of early cancers in Barrett's high-grade dysplasia. Am J Gastroenterol 2000 95 : 3089 96.
37. Buttar NS, Wang KK, Sebo TJ, et al. Extent of high-grade dysplasia in Barrett's esophagus correlates with risk of adenocarcinoma. Gastroenterology 2001 120 : 1630 9.
38. Nigro JJ, Hagen JA, DeMeester TR, et al. Occult esophageal adenocarcinoma. Extent of disease and implications for effective therapy. Ann Surg 1999 230 : 433 40.
39. Levine DS, Reid BJ. Endoscopic biopsy technique for acquiring larger mucosal samples. Gastroenterologist 1991 37 : 332 37.
40. Falk GW, Skacel M, Gramlich TL, et al. Fluorescence in situ hybridization of cytologic specimens from Barrett's esophagus: a pilot feasibility study. Gastrointest Endosc 2004 60 (1 280 84.
41. Brankley SM, Wang KK, Harwood AR, et al. The development of a fluorescence in situ hybridization assay for the detection of dysplasia and adenocarcinoma in Barrett's esophagus. JMD 2006 8 (2 260 67.
42. Sampliner RE, Fennerty MB, Garewal HS. Reversal of Barrett's esophagus with acid suppression and multipolar electrocoagulation: preliminary results. Gastrointest Endosc 1996 44 : 532 35.
43. Overholt B, Lightdale C, Wang K, et al. Photodynamic therapy (PDT) with porfimer sodium for the ablation of high-grade dysplasia in Barrett's esophagus (BE): international, partially blinded randomized phase III trial. Gastrointest Endosc 2005 62 : 488 98.
44. Berenson MM, Johnson TD, Markowitz NR, et al. Restoration of squamous mucosa after ablation of Barrett's esophagus epithelium. Gastroenterology 1993 104 : 1686 91.
45. Dulai GS, Jensen DM, Cortina G, et al. Randomized trial of argon plasma coagulation versus multipolar electrocoagulation for ablation of Barrett's esophagus. Gastrointest Endosc 2005 61 : 232 40.
46. Sharma VK, Wang KK, Overholt BF, et al. Balloon-based, circumferentiao, endoscopic ablation of Barrett's esophagus: 1-year follow-up of 100 patients. Gastrointest Endosc 2007 65 : 185 95.
47. Byrne JP, Armstrong GR, Attwood SEA. Restoration of the normal squamous lining in Barrett's esophagus by argon beam plasma coagulation. Am J Gastroenterol 1998 93 : 1810 15.
48. Pech O, Gossner L, May A, et al. Long-term results of photodynamic therapy with 5-aminolevulinic acid for superficial Barrett's cancer and high-grade intraepithelial neoplasia. Gastrointest Endosc 2005 62 : 24 30.
49. Hage M, Siersema PD, van Dekken H, et al. 5-aminolevulinic acid photodynamic therapy versus argon plasma coagulation for ablation of Barrett's oesophagus: a randomised trial. Gut 2004 53 : 785 90.
50. Sharma P, Wani S, Weston AP, et al. A randomised controlled trial of ablation of Barrett's oesophagus with multipolar electrocoagulation versus argon plasma coagulation in combination with acid suppression: long term results. Gut 2006 44 : 1233 39.
51. Johnston MH, Eastone JA, Horwhat JD, et al. Cryoablation of Barrett's esophagus: a pilot study. Gastrointest Endosc 2005 62 (6 842 8.
52. Tseng EE, Wu TT, Yeo CF, et al. Barrett's esophagus with high grade dysplasia: surgical results and long-term outcome - an update. J Gastrointest Surg 2003 7 : 164 71.
53. Oh DS, Hagen JA, Chandrasoma PT, et al. Clinical biology and surgical therapy of intramucosal adenocarcinoma of the esophagus. J Am Coll Surg 2006 203 (2 152 61.
54. Schnell TG, Sontag SJ, Chejfec G, et al. Long-term nonsurgical management of Barrett's esophagus with high-grade dysplasia. Gastroenterology 2001 120 : 1607 19.
55. Nguyen NT, Schauer P, Luketich JD. Minimally invasive esophagectomy for Barrett's esophagus with high-grade dysplasia. Surgery 2000 127 : 284 90.
56. Luketich JD, Landreneau RJ. Minimally invasive resection and mechanical cervical esophagogastric anastomotic techniques in the management of esophageal cancer. J Gastrointest Surg. 2004 2004 (8).
57. Banki F, Mason RJ, DeMeester SR, et al. Vagal-sparing esophagectomy: a more physiologic alternative. Ann Surg 2002 236 (3 324 36.
58. Maish MS, DeMeester SR. Endoscopic mucosal resection as a staging technique to determine the depth of invasion of esophageal adenocarcinoma. Ann Thorac Surg 2004 78 : 1777 82.
59. Prasad GA, Wang KK, Buttar NS, et al. Long term survival following endoscopic and surgical treatment of high grade dysplasia in Barrett's esophagus. Gastroenterology 2007 132 : 1226 33.
60. Goda K-I, Tajiri H, Ikegami M, et al. Usefulness of magnifying endoscopy with narrow band imaging for the detection of specialized intestinal metaplasia in columnar lined esophagus. Gastrointest Endosc 2007 65 (1 36 46.
61. Anagnostopoulos GD, Yao K, Kaye P, et al. Novel endoscopic observation in Barrett's oesophagus using high resolution magnification endoscopy and narrow band imaging. Aliment Pharmacol Therap 2007 26 (3 501 07.
62. Ross AS, Noffisinger A, Waxman I. Narrow band imaging directed EMR for Barrett's esophagus with high grade dysplasia. Gastrointest Endosc 2007 65 (1 166 69.
63. Sharma P, Bansal A, Mathur S, et al. The utility of a novel narrow band imaging endoscopy system in patients with Barrett's esophagus. Gastrointest Endosc 2006 64 (2 167 75.
64. Kara MA, Peters FP, Fockens P, et al. Endoscopic video-autofluorescence imaging followed by narrow band imaging for detecting early neoplasia in Barrett's esophagus. Gastrointest Endosc 2006 64 (2 176 85.
65. Canto M, Setrakian S, Willis J, et al. Methylene blue directed biopsies improve detection of intestinal metaplasia and dysplasia in Barrett's esophagus. Gastrointest Endosc 2000 51 : 560 8.
66. Ragunath K, Krasner N, Raman VS, et al. A randomized, prospective cross-over trial comparing methylene blue-directed biopsy and conventional random biopsy for detecting intestinal metaplasia and dysplasia in Barrett's esophagus. Endoscopy 2003 35 (12 998 1003.
67. Lim CH, Rotimi O, Dexter SPL, et al. Randomized crossover study that used methylene blue or random 4-quadrant biopsy for the diagnosis of dysplasia in Barrett's esophagus. Gastrointest Endosc 2006 64 (2 195 99.
68. Horwhat JD, Maydonovitch CL, Ramos F, et al. A randomized comparison of methylene blue-directed biopsy versus conventional four-quadrant biopsy for the detection of intestinal metaplasia and dysplasia in patienst with long-segment Barrett's esophagus. Am J Gastroenterol 2007 102 (10 M, Herrera I, Essenfeld H, et al. Enhanced magnification endoscopy: a new technique to identify specialized intestinal metaplasia in Barrett's Esophagus. Gastrointest Endosc 2001 53 : 559 65.
69. Kiesslich R, Gossner L, Goetz M, et al. In vivo histology of Barrett's esophagus and associated neoplasia by confocal laser endomicroscopy. Clin Gastroenterol and Hepatol 2006 4 (8 979 87.
70. Evans JA, Bouma BE, Bressner J, et al. Identifying intestinal metaplasia at the squamocolumnar junction by using optical coherence tomography. Gastrointest Endosc 2007 65 (1 50 6.
71. Georgakoudi I, Jacobson BC, Van Dam J, et al. Fluorescence, reflectance, and light-scattering spectroscopy for evaluating dysplasia in patients with Barrett's esophagus. Gastroenterology 2001 120 : 1620 29.
72. Rabinovitch P, Longton G, Blount P, et al. Predictors of progression in Barrett's esophagus III: baseline flow cytometric variables. Am J Gastroenterol 2001 96 : 3071 83.
73. Reid B, Prevo L, Galipeau P, et al. Predictors of progression in Barrett's esophagus II: Baseline 17p (p53) loss of heterozygosity identifies a patient subset at increased risk for neoplastic progression. Am J Gastroenterol 2001 96 : 2839 48.
74. Sato F, Meltzer SJ. CpG island hypermethylation in progression of esophageal and gastric cancer. Cancer 2005 106 : 483 93.
75. Corley DA, Kerlikowske K, Verma R, et al. Protective association of aspirin/NSAIDs and esophageal cancer: a systematic review and meta-analysis. Gastroenterology 2003 124 : 47 56.
76. Vaughan TL, Dong LM, Blount P, et al. Non-steroidal anti-inflammatory drugs and risk of neoplastic progression in Barrett's oesophagus: a prospective study. Lancet Oncol 2005 6 : 945 52.
77. Heath EI, Canto MI, Piantadosi S, et al. Secondary chemoprevention of Barrett's esophagus with celecoxib: results of a randomized trial. J Natl Cancer Inst 2007 99 : 545 57.
78. Buttar NS, Wang KK, Leontovich O, et al. Chemoprevention of esophageal adenocarcinoma by COX-2 inhibitors in an animal model of Barrett's esophagus. Gastroenterology 2002 122 : 1101 12.
79. Jankowski J, Barr H. Improving surveillance for Barrett's oesophagus. BMJ. 2006 322 : 1512.
80. El-Serag HB, Aguirre TV, Davis S, et al. Proton pump inhibitors are associated with reduced incidence of dysplasia in Barrett's esophagus. Am J Gastroenterol 2004 99 : 1877 83.
81. Hillman LC, Chiragakis L, Shadbolt B, et al. Proton-pump inhibitor therapy and the development of dysplasia in patients with Barrett's oesophagus. Med J Aust 2004 180 (8 387 91.
82. Ouatu-Lascar R, Fitzgerald RC, Triadafilopoulos G. Differentiation and proliferation in Barrett's esophagus and the effects of acid suppression. Gastroenterology 1999 : 117 : 327 35.
83. Hofstetter WL, Peters JH, DeMeester T, et al. Long-term outcome of antireflux surgery in patients with Barrett's esophagus. Ann Surg. 2001 234 (532 9).
84. Csendes A, Burdiles P, Braghetto I, et al. Adenocarcinoma appearing very late after antireflux surgery for Barrett's esophagus: long term follow up, review of the literature, and addition of six patients. J Gastrointest Surg 2004 8 (4 434 41.
85. Streitz JM, Andrews CW, Ellis FH. Endoscopic surveillance of Barrett's esophagus: does it help? J Thorac Cardiovasc Surg. 1993 105 : 383 88.
86. Peters JH, Clark GWB, Ireland AP, et al. Outcome of adenocarcinoma arising in Barrett's esophagus in endoscopically surveyed and nonsurveyed patients. J Thorac Cardiovasc Surg 1994 108 : 813 22.
87. vanSandick JW, vanLanschot JJB, Kuiken BW, et al. Impact of endoscopic biopsy surveillance of Barrett's oesophagus on pathological stage and clinical outcome of Barrett's carcinoma. Gut 1998 43 : 216 22.
88. Incarbone R, Bonavina L, Saino G, et al. Outcome of esophageal adenocarcinoma detected during endoscopic biopsy surveillance for Barrett's esophagus. Surg Endosc 2002 16 (2 263 66.
89. Ferguson MK, Durkin A. Long-term survival after esophagectomy for Barrett's adenocarcinoma in endoscopically surveyed and nonsurveyed patients. J Gastrointest Surg 2002 6 (1 29 35.
90. Fountoulakis A, Zafirellis K, Dolan K, et al. Effect of surveillance of Barrett's oesophagus on the clinical outcome of oesophageal cancer. Br J Surg 2004 91 : 997 1003.